Nippon Suisan Kaisha, also known as Nissui, plans to become the world's largest producer of eicosapentaenoic acid (EPA), a fatty acid found in the flesh of coldwater fish that is thought to boost brain function and cardiovascular health.
The Tokyo-based company has already started to control the biggest slice of the market for medical-use EPA, which can be used to treat hyperlipidemia, an elevated level of fat particles in the blood, Nikkei Asian Review reported.
Health experts have welcomed the initiative as EPA can prevent blood from easily clotting and it is used to prevent arteriosclerosis, the buildup of fats, cholesterol and other substances on the walls of arteries; heart attacks; and other conditions.
Nissui’s plans started being developed in December, when the firm’s board announced that it would spend JPY 8 billion (USD 71.2 million...
HSMI evidence detected in farmed salmon Canada
A team of international researchers has diagnosed a potential heart and skeletal muscle inflammation in farmed Atlantic salmon samples collected from a BC aquaculture facility in 2013-2014.